On Tuesday, Shares of Zimmer Biomet Holdings Inc (NYSE:ZBH), added 3.53% and closed at $101.45 in the last trading session. The last trading range of the stock ranges between $98.37 and $102.04. The company’s Market capitalization is $20.31 Billion with the total Outstanding Shares of 200.30 million. During the 52-week trading session the minimum price at which share price traded, registered at $88.27 and reached to max level of $133.21. The EPS of company is strolling at 1.79. Zimmer Biomet Holdings, Inc. (NYSE and SIX: ZBH), a global leader in musculoskeletal healthcare, recently declared an update on its Investigational Device Exemption (IDE) clinical trial evaluating the use of autologous concentrated bone marrow aspirate (cBMA), prepared via the MarrowStim™ PAD Kit, for the treatment of critical limb ischemia (CLI). The trial, known as MOBILE (MarrOwStim™ PAD Kit for the Treatment of Critical LimB IschemIa in Subjects with Severe Peripheral ArteriaL DiseasE), is the first pivotal study of its kind to complete enrollment and 1-year follow-up in a challenging patient population with a high mortality risk. A preliminary analysis of a partial data set found that treatment with cBMA improved amputation-free survival contrast to placebo, while maintaining a safety profile comparable to placebo. The final analysis of the MOBILE data will form the basis of the Company’s U.S. regulatory submission, which is presently being prepared.
“We’re excited to declare positive progress on our investigational treatment for critical limb ischemia that anchors our emerging biologics pipeline and highlights the breadth of our innovative research and development capability,” said David Nolan, Group President, Biologics, Extremities, Sports Medicine, Surgical, Trauma, Foot and Ankle and Office Based Therapies for Zimmer Biomet. “The positive data from our IDE trial places Zimmer Biomet at the forefront of advancing our understanding of the clinical utility of autologous cell therapy, which is one of the most promising areas within biologics. We look forward to concluding the analysis of the full data set, unveiling the final results, and finalizing our regulatory submission to the FDA.”
Shares of International Business Machines Corp. (NYSE:IBM), jumped 0.29% and closed at $158.67 in the last trading session. The last trading range of the stock ranges between $157.55 and $159.15. The company’s Market capitalization is $148.01 Billion with the total Outstanding Shares of 950.85 million. During the 52-week trading session the minimum price at which share price traded, registered at $116.90 and reached to max level of $165.00. The EPS of company is strolling at 12.27. SC16 – Recently Supermicro ( NASDAQ : SMCI ) and IBM ( NYSE : IBM ) have extended their multi-faceted long-term technology relationship. Supermicro has joined the OpenPOWER Foundation, an open development community that leverages the IBM POWER architecture.
Supermicro is joining IBM, Google, NVIDIA, Canonical, Rackspace and more than 270 other leading technologists working collaboratively on advanced server, storage, and networking acceleration technology in addition to industry leading open source software aimed at delivering more choice, control, and flexibility to developers of next-generation heterogeneous cloud datacenters. The group makes POWER-based hardware and software available to open development, together with making POWER intellectual property licensable to others, greatly expanding the ecosystem of innovators on the platform.